Vault-13

BOLT BIOTHERAPEUTICS INC BOLT

COM NEW · Common Stock · CUSIP 097702203

26 institutional holders
829,184829.2k shares reported held*
$4.8mreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($336.7k this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $5.74.

Biggest buyers

Vivo Capital, LLC New +176,064+176.1k
TANG CAPITAL MANAGEMENT LLC New +166,879+166.9k
Sofinnova Investments, Inc. New +137,721+137.7k
Pivotal bioVenture Partners Investment Advisor LLC New +94,573+94.6k
VANGUARD GROUP INC New +58,484+58.5k
Nan Fung Group Holdings Ltd New +58,347+58.3k
SAMSARA BIOCAPITAL, LLC New +52,456+52.5k
Board of Trustees of The Leland Stanford Junior University New +35,978+36.0k
Pfizer Inc New +31,305+31.3k
GEODE CAPITAL MANAGEMENT, LLC New +18,533+18.5k

Biggest sellers

None

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
RENAISSANCE TECHNOLOGIES LLC 13G · institution new · filed 2026-08-13 5.1% new 98.6k≈ $379.7k 2026-08-13

Fell to 5% or below in the last year: Pivotal bioVenture Partners Fund I, L.P. (4.6%, 2026-02-26), Vivo Panda Fund, L.P. (3.8%, 2026-02-13)

Insider purchases and sales in Q2 2025

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
404Q3 23: 0 buyingQ3 23: 0 sellingQ4 23: 4 buyingQ4 23: 1 sellingQ4 23Q1 24: 0 buyingQ1 24: 0 sellingQ2 24: 2 buyingQ2 24: 0 sellingQ2 24Q3 24: 0 buyingQ3 24: 0 sellingQ4 24: 2 buyingQ4 24: 0 sellingQ4 24Q1 25: 0 buyingQ1 25: 0 sellingQ2 25: 2 buyingQ2 25: 0 sellingQ2 25
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q3 20230—0——
Q4 20234$9.1k1$176.8k—
Q1 20240—0——
Q2 20242$1.6k0——
Q3 20240—0——
Q4 20242—0——
Q1 20250—0——
Q2 20252$6860——
DateInsiderTradeSharesPrice ValueTheir holding
2025-06-06 Quinn William P. President, CEO and CFO, director Bought 125 $5.49 $686125 shares +6%
2025-06-06 Nemec Sarah Senior VP, Finance and PAO Bought 125 $5.49 $686125 shares +15%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q2 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Vivo Capital, LLC 0.10% of their portfolio Palo Alto, CA 176,064176.1k $986.0k $986.0k 0.10% New
2 TANG CAPITAL MANAGEMENT LLC 0.05% of their portfolio SAN DIEGO, CA 166,879166.9k $962.9k $962.9k 0.05% New
3 Sofinnova Investments, Inc. 0.05% of their portfolio Menlo Park, CA 137,721137.7k $794.6k $794.6k 0.05% New
4 Pivotal bioVenture Partners Investment Advisor LLC 0.34% of their portfolio SAN FRANCISCO, CA 94,57394.6k $545.7k $545.7k 0.34% New
5 VANGUARD GROUP INC 0.00% of their portfolio Valley Forge, PA 58,48458.5k $341.0k $341.0k 0.00% New
6 Nan Fung Group Holdings Ltd 0.53% of their portfolio KAI TAK, K3 58,34758.3k $336.7k $336.7k 0.53% New
7 SAMSARA BIOCAPITAL, LLC 0.06% of their portfolio PALO ALTO, CA 52,45652.5k $302.7k $302.7k 0.06% New
8 Board of Trustees of The Leland Stanford Junior University 0.02% of their portfolio STANFORD, CA 35,97836.0k $207.6k $207.6k 0.02% New
9 Pfizer Inc 0.03% of their portfolio New York, NY 31,30531.3k $180.6k $180.6k 0.03% New
10 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 18,53318.5k $108.1k $108.1k 0.00% New
11 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 18,32518.3k $105.7k $105.7k 0.00% New
12 Squarepoint Ops LLC 0.00% of their portfolio NEW YORK, NY 12,38812.4k $72.2k $72.2k 0.00% New
13 ADAR1 Capital Management, LLC 0.01% of their portfolio AUSTIN, TX 10,82310.8k $62.4k $62.4k 0.01% New
14 BlackRock, Inc. 0.00% of their portfolio New York, NY 10,55010.6k $60.9k $60.9k 0.00% New
15 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 3,5793.6k $20.7k $20.7k 0.00% New
16 NewEdge Advisors, LLC 0.00% of their portfolio NEW ORLEANS, LA 483483 $2.8k $2.8k 0.00% New
17 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 395395 $2.3k $2.3k 0.00% New
18 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 282282 $1.6k $1.6k 0.00% New
19 UBS Group AG 0.00% of their portfolio ZURICH, V8 183183 $1.1k $1.1k 0.00% New
20 FMR LLC 0.00% of their portfolio BOSTON, MA 121121 $705 $705 0.00% New
21 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 4343 $251 $251 0.00% New
22 SBI Securities Co., Ltd. 0.00% of their portfolio TOKYO, M0 1010 $58 $58 0.00% New
23 BARCLAYS PLC 0.00% of their portfolio LONDON, X0 66 $35 $35 0.00% New
24 SALEM INVESTMENT COUNSELORS INC 0.00% of their portfolio WINSTON-SALEM, NC 22 $12 $12 0.00% New
25 DANSKE BANK A/S 0.00% of their portfolio COPENHAGEN V, G7 11 $6 $6 0.00% New
26 CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio BIRMINGHAM, AL 00 $0 $0 — New